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Abstract
Background
In high income countries, cancer is one of the leading causes of death, with co-morbid
depression contributing to the risk of increased mortality. However, both cancer and depres-
sion are neglected conditions in low income countries. The current study assessed the mag-
nitude of depression and the association of pain complaints with depression among patients
with cancer in a low income country.
Method
In this cross-sectional study participants were 390 patients with established diagnosis of
cancer, who were recruited consecutively when visiting a tertiary treatment centre in Addis
Ababa, Ethiopia. The occurrence of depression was determined using the nine items Patient
Health Questionnaire (PHQ-9). Major depressive disorder was confirmed: (1) when five or
more of the PHQ-9 symptoms were endorsed as occurring for at least ‘more than seven
days’, with the exception of suicidal ideation item which counted as a positive rating if it had
occurred even once in the previous fifteen days. (2) one of the symptoms has to be either
depressed mood or loss of interest. Pain complaint was measured by Numeral Rating Scale
(NRS) and severity of pain was assessed using Verbal Rating Scale (VRS).
Results
The prevalence of major depressive disorder was 16.4% (95%CI: 13.1%, 20.4%), and sub-
threshold depression was 17.4% (95%CI: 14.0%, 21.5%). Pain complaints occurred in
69.0% (95%CI: 64.3%, 73.4%) of the participants. The odds of having a major depressive
symptom was over four times higher among participants who had pain.
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Limitations
The study was cross sectional and liable to recall bias. Recruitment was carried out in a ter-
tiary referral hospital, which might lead to the selection of more economically well-off and
educated participants limiting generalizability of the study. Moreover, we did not control for
cancer types, which may be related to pain and the experience of depression. Some of the
somatic symptoms in PHQ9 may also be related to the cancer itself.
Conclusions
This study highlights the clinical significance of both depression and pain complaints in
patients with cancer in a low income country. Exploration of the impact of depressive disor-
ders on quality of life and outcome of cancer is an important area for further research in low
income countries.
Introduction
One in six deaths worldwide are due to cancer, establishing it as the second leading cause of
death globally [1]. Approximately 14 million new cases of cancer were expected in 2012, with
anticipated increase of 70% over the coming 20 years [2]. More than 70% of all deaths occur in
low and middle-income countries[3, 4]. In Africa, the incidence of cancer and associated mor-
tality continues to rise [5] with 645,000 new cases and 456,000 deaths in 2012 [6]. However, it
receives little attention from a public health perspective. Similarly, although cancer is one of
the major causes of death in Ethiopia, it is a far more neglected problem[7]. Despite the limited
data on the epidemiology of cancer in Ethiopia, in 2008, the number of new cases of cancer
was reported to be 51,700, with 41,600 deaths. The probability of dying from cancer before the
age of 75 was 9.4% [8]. Among non communicable diseases, cancer is responsible for the sec-
ond highest mortality in the country next to cardiovascular diseases [9–11]. The five year prev-
alence of cancer was reported to be 0.22%. Breast cancer, cervical cancer and cancer of the
esophagus were the most prevalent forms of cancer. Virtually no systematic data exists on the
cost of cancer from Ethiopia. There is limited service for patients with cancer in Ethiopia.
Although most referral hospitals provide diagnostic and limited treatment services, most of
the care for cancer is provided by Tikur Anbessa Specialized Hospital (TASH), a tertiary refer-
ral hospital located in the capital city Addis Ababa. TASH has the only radiotherapy and pallia-
tive care service in the country [12].
Among other causes, one of the factors that seem to increase death related to cancer is
depression [13, 14], one study for example demonstrating a 19% increase in the relative risk
for mortality among the depressed group [13]. Early diagnosis and treatment of co-morbid
depression, which affects 10.8% to 61.6% of patients with cancer [15, 16], may help to mini-
mize expenditures for medical costs, symptom burden, poor self care practice and adherence,
which are mechanisms by which depression may increase morbidity and mortality in chronic
conditions [13, 17–20].
Depression is a common and most burdensome neuropsychiatric condition, with the Dis-
ability adjusted life years projected to rank second by 2020. From African regions, north Africa
has the highest depression rates [21]. The latest study in Ethiopia that assessed about 10,000
adults reported the prevalence of depression to be 9.1% (95% CI: 8.39, 9.90) [22]. However,
subthreshold conditions, i.e., occurrence of clinically significant symptoms of depression with-
out meeting the criteria for major depressive disorder, are more common and may accompany
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physical illnesses. Patients with subthreshold states have a higher risk of developing a major
depressive disorder in the long run, with an estimated risk of up to 67%. This risk of develop-
ing major depressive disorder increases when the severity of the depressive symptoms is higher
and when co-morbid medical conditions are present. When these occur, suicidal ideation may
arise in up to 90% [23]
Depression commonly co-exists with pain. Pain is the most important symptom affecting
quality of life of patients. Pain is also a common problem in patients with cancer with reported
prevalence of 44% to 87% [24, 25].
Pain and depression together can worsen the clinical condition of a patient than either con-
dition alone; and there is strong association between the two [26]. Pain is a commonly
reported complaint among patients with depression. For example, in a systematic review syn-
thesizing 14 facility based studies, the mean prevalence of pain in depressed individuals was
65% [27].Depression may cause pain and pain may cause depression [27–29]; and in fact some
have argued that pain might play a causal role in producing depression [26] and that both
depression and pain may share the same neurotransmitter pathways [27]. Depression in
patients with pain is associated with more pain and greater impairment. Treatment of both
conditions at the same time has the potential of improving both conditions [27].Even though
depression is a major public health problem everywhere and of importance in the course of
cancer, few studies have explored its effect on patients with cancer either alone or as co-morbid
condition with pain in low income countries like Ethiopia. Therefore, this study assessed the
magnitude of depression and pain complaints and their associations as well as the level of func-
tional impairment due to depressive symptoms were evaluated among adult patients with
established diagnosis of cancer attending a tertiary treatment center in Addis Ababa, Ethiopia.
Materials and methods
Study design and setting
This cross-sectional study was conducted in a public tertiary treatment centre in Addis Ababa.
In addition to inpatient services, the centre provides radiotherapy and chemotherapy services.
The Radiotherapy unit accepts referrals from all over the country and offers care for an average
of 118 patients per week. Women make up 70% of the patients using this service.
Study participants
Study was conducted in January 2012. Patients, 18 years of age and above, with established
diagnosis of cancer for a minimum of one month were eligible for the study. Patients who
were unable to communicate either because of illness or inability to speak the language of
interview (Amharic) were not included. Inpatients were approached in the wards while outpa-
tients were approached while waiting for their follow up or therapy. Interviews were carried
out in a private room near the waiting area. Consenting consecutive patients were recruited
until the required sample size (shown below) was obtained. The interview was conducted in
Amharic and took an average of 20 minutes.
Sample size. Sample size was calculated assuming that the prevalence of depression and
pain among patients with cancer to be 37% and 73% respectively [25] with an additional
assumption of non-response rate of 10%, 95% level of confidence and a margin of error of 5%.
Instrument and data collection procedures
Depression was assessed using a validated Amharic version of the 9-item of the patient health
questionnaire (PHQ-9) as the criterion standard for assessing both major depression and
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Subthreshold depression [30, 31]. The PHQ rates for each of the 9 symptoms of depression
contained in the Diagnostic and Statistical Manual of Mental Disorders, 4th revision (DSM-
IV) through patients’ self-report [32]. Each symptom is rated over a 2-week period and in four
severity categories based on duration and persistence: “0” (not at all), “1” (symptoms occurred
for less than seven days), “2” (symptoms occurred for more than seven days), or “3” (symp-
toms occurred nearly every day for at least the two week period). The PHQ-9 has demon-
strated acceptable reliability, validity, sensitivity, and specificity [30]. The instrument was also
used to assess depression co-morbidity with chronic illness including cancer [33] and was pre-
viously validated in Ethiopia [31].As briefed in Table 1 diagnosis of major depressive disorder
was made if five or more symptoms have persisted for over 50% of the time and sub threshold
depression was identified if among the 9 items of the PHQ 9, two to four of the symptoms
have been persisting for more than 50% of the time for all symptoms. In either of these sub-
types, suicidal ideation item is an exception which is counted as a positive rating if it had
occurred even once in previous fifteen days. For the score based classification, we used the
PHQ score range of 5–9 for mild, 10–14 for moderate, 15–19 for moderately severe, and above
a score of 20 for severe depression. However, since several studies have used a binary categori-
zation based on a cutoff value of 10 as the threshold for diagnosing depression, we have con-
ducted a sensitivity analysis with this cutoff.
Functional impairment of the patient as the result of depressive symptoms was assessed
using the 10thPHQ item with four response categories. The administered item states “If you
checked off any problems, how difficult have these problems made it for you to do your work,
take care of things at home, or get along with other people?” and the response categories are
“Not difficult at all”, “Somewhat difficult”, “Very difficult” and “Extremely difficult”.
Pain was assessed using patients’ self report in Numeric and Verbal Rating Scale (NRS),
which measures perceived pain on a 0–10 scale (0 = no pain and 10 = worst imaginable pain).
Pain ratings of more than three usually indicate pain that interferes with daily activities and
pain rating of 10 is the most severe pain imaginable. Verbal Rating Scale (VRS) is an ordinal
scale of measurement for rating pain complaint based on the patient’s description. The
response categories of VRS are none, mild, moderate, or severe. Both NRS and VRS are a vali-
dated tests in measuring pain exacerbation and have been used for measuring pain extent on
cancer patients among the two measures NRS is a preferred option [24, 34–36]. However, in
Ethiopian context VRS has been the most common approach to assess pain[37, 38]
Additionally, Patients were directly interviewed using a local questionnaire consisting of
the socio demographic characteristics, such as sex, age, educational status, marital status,
Table 1. Depression diagnosis: Criterion based and score based classification.
Basis for
classification
Class or condition Symptom or score specification
Criterion-based
Major depression 1 or 2 DSM Core symptoms
At least 3 additional symptoms (giving a total of 5 or more
symptoms)
Sub-threshold
depression
1 or 2 DSM Core symptoms
0 to 3 additional symptoms (giving a total of 2–4 symptoms)
Score-based
Mild 5–9
Moderate 10–14
Moderately severe 15–19
Severe 20 and higher
https://doi.org/10.1371/journal.pone.0193713.t001
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residency, employment status, regular source of income and perceived social support. Clinical
characteristics of patients were acquired by directly asking patients and using the medical rec-
ords of the hospital. Patients were directly asked for their Belief on cancer curability, health sat-
isfaction, presence of other chronic illness and presence and extent of perceived pain. Patients
who had just one visit, were considered as a new patient, while patients who had more than
one visit were considered as a follow up patient. Cancer type and stage, medication type and
duration since diagnosis, were extracted from the medical records following the latest clinical
visit. The diagnosis confirmed by the oncologist based on the histo-pathological and radio-
graphic findings was used for the diagnostic information.
Data management
Data were entered and cleaned using EpiInfo Version 3.5.4., and exported to the Statistical
Packages for Social Sciences, version 20 (SPSS 20), for analysis. Descriptive statistical methods
were used to summarize data on socio-demographic and clinical characteristics. Bivariate anal-
ysis was employed to determine unadjusted associations of socio-demographic and clinical
characteristics, including pain, with depression. Factors found to be significant in bivariate
analysis were included in multivariable logistic regression model to evaluate adjusted effects
of different factors on the odds of having Major depression. The effect of pain on the odds of
having depression was investigated in detail by adjusting for one variable at a time and then
adjusting fully for potential confounding variables. The impacts of the severity of pain assessed
with the two measures were adjusted separately in the multivariable logistic regression to
avoid Multi-colinearity. However, the effect of all other variables was adjusted for the effect of
pain as measured by VRS as VRS is more explicit.
Ethical considerations
Ethical clearance was obtained from Haramaya University ethical clearance committee and
the Institutional Ethical Review Board of the College of Health Sciences, Addis Ababa Univer-
sity (ref no 041/2011). Informed consent was obtained from all participants involved in the
study. All participants with moderate or severe depressive disorder and/ or sucidality were
referred to a nearby psychiatry clinic or the psychiatric hospital in Addis Ababa for a psychiat-
ric assessment and management.
Result
Socio-demographic characteristics
Background characteristics of the study participants are summarized in Table 2. From the total
of 395 adult cancer patients targeted for the study, 390 patients were enrolled and participated
in the study, resulting in a response rate of 98.7%. Four patients did not consent and one did
not finish the interview because of health issues. The respondents were predominantly female
(73.1%; n = 285), with a mean age of 43.5 (SD = 13.0) years.
Clinical characteristics of respondents
Clinical characteristics of study participants are summarized in Table 3. Participants were pre-
dominantly affected by Breast cancer (29.5%; 114/387) and cervical cancer (22.7%; 88/387).
Sizable proportion of the respondents were in a post operational stage (43.6%) and on follow
up (71.8%); more than half (51.6%) were taking chemotherapy. The majority had their diagno-
sis confirmed less than a year ago (64.4%) and (47.2%) reported to have symptoms of cancer
for 1–3 years. More chronic illness was reported by 20.8%.
Depression and pain among cancer patients
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Magnitude of depression and depressive symptoms
According to DSM related criterion diagnosis, the prevalence of major depression was 16.4%
(95%CI: 13.1%, 20.4%) and that of subthreshold depression was17.4% (95%CI: 14.0%, 21.5%).
Level of functional impairment among patients with subthreshold depression was relatively
low compared to patients with major depression (Fig 1).
Using PHQ-9 score cut off of 5 for mild, 10 for moderate, 15 for moderately severe, and 20
for severe depression, the prevalence of depression was 28.7%, 22.5%, 9.8% and 4.6% respec-
tively. Functional impairment among these groups shows an increasing trend in relation to the
severity of the depression (Fig 2).
Among those with major depression and subthreshold depression, feeling tired and feeling
down were the commonest symptoms occurring respectively in 95.3% and 89.1% in those with
major depression and 61.8% and 67.6% in those with subthreshold depression. Suicidal idea-
tion was observed in 60.9% of those with major depression and 19.1% of those with subthresh-
old depression (Fig 3).
Table 2. Socio-demographic characteristics and correlates of depression among study participants (n = 390).
Socio-demographic characteristics of participants Number (%) interviewed Major Depression Crude
OR (95% CI)Number (%) Yes Number (%) No
Sex
Female 285 (73.1) 45(15.8) 240(84.2) 0.58(0.47, 1.53)
Male 105 (26.9) 19(18.1) 86(81.9) 1.00
Age
< 35 93 (23.8) 12(12.9) 81(87.1) 0.96(0.41, 2.27)
35–44 109 (27.9) 25(22.9) 84(77.1) 1.93(0.91, 4.11)
45–54 98 (25.1) 15(15.3) 83(84.7) 1.18(0.52, 2.67)
>54 90 (23.1) 12(13.3) 78(86.7) 1.00
Educational Status
No formal education 111 (28.5) 18(16.2) 93(83.8) 1.62(0.67, 3.95)
Primary education(Grade 1–8) 84 (21.5) 19(22.6) 65(77.4) 2.45 (1.00, 5.98)
Secondary Education(Grade 9–12) 120 (30.8) 19(15.8) 101(84.2) 1.58(0.65, 3.81)
Higher education
(Anything above grade 12 e.g. Diploma, Degree. . .)
75 (19.2) 8(10.7) 67(89.3) 1.00
Marital Status
Single 61 (15.6) 9(14.8) 52(85.2) 1.00
Married 239 (61.3) 36(15.1) 203(84.9) 0.98 (0.44, 2.15)
Formerly Married 90 (23.1) 19(21.1) 71(78.9) 1.51(0.81, 2.80)
Residence
Addis Ababa 213(54.6) 30(14.1) 183(85.9) 1.00
Outside Addis Ababa 177 (45.4) 34(19.2) 143(80.8) 1.45 (0.85, 2.48)
Employment status
Unemployed 212 (54.4) 40(18.9) 172(81.1) 1.49 (0.86, 2.59)
Employed 178 (45.6) 24(13.5) 154(86.5) 1.00
Regular source of Income
Yes 149 (38.2) 16(10.7) 133(89.3) 1.00
No 241 (61.8) 48(19.9) 193(80.1) 2.07 (1.13, 3.80)
Perceived Social support
Good 319 (81.8) 44(13.8) 275(86.2) 1.00
Poor 71 (18.2) 20(28.2) 51(71.8) 2.45 (1.34, 4.50)
https://doi.org/10.1371/journal.pone.0193713.t002
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Sensitivity analysis
The prevalence of MDD using the score based cutoff diagnosis was more than twice that of the
criterion base (DSM IV) diagnosis (39.9%) but all participants who were diagnosed with MDD
as per the criterion diagnosis were also diagnosed with depression in the score based system.
In the regression model, all significantly associated factors in the criterion based diagnosis,
remained significant except social support. Moreover, three additional factors (lack of regular
Table 3. Unadjusted effects of selected clinical indicators on the odds of having major depression.
Clinical Characteristics of participants Number (%) interviewed Major Depression Crude
OR (95% CI)Number (%) yes Number (%) no
Patient category
New 110 (28.2) 12(10.9) 98(89.1) 1.00
Follow up 280 (71.8) 52(18.6) 228(81.4) 1.86(0.95, 3.64)
Cancer Type
Breast 114 (29.5) 14(12.3) 100(87.7) 0.65 (0.29, 1.42)
Cervical 88 (22.7) 13(14.8) 75 (885.2) 0.52 (0.24, 1.12)
Head and Neck 38 (9.8) 5(13.2) 33(86.8) 0.56 (0.19, 1.65)
Colorectal 33 (8.5) 7(21.2) 26(78.8) 1.00 (0.38, 2.68)
Sarcoma 29 (7.5) 6 (20.7) 23(979.3) 0.97(0.34, 2.74)
Others 85 (22.0) 18 (21.2) 67(78.8) 1.00
Stage of cancer (n = 362)
Early (I&II) 63 (17.4) 9 (14.3) 54 (85.7) 1.00
Advanced (III, IV &V) 141 (39.0) 30 (21.3) 111(78.7) 1.62 (0.72, 3.66)
Post Operational Stage 158 (43.6) 19 (12.0) 139 (88.0) 0.82 (0.35, 1.93)
Medication for cancer
Radiotherapy 113 (29.3) 26 (23.0) 87 (77.0) 1.68 (0.94, 3.02)
Radiotherapy +chemotherapy 74 (19.2) 7 (9.5) 67 (90.5) 0.59 (0.25, 1.40)
Chemotherapy 199 (51.6) 30 (15.1) 169 (84.9) 1.00
Duration since case is confirmed
 a year 251 (64.4) 39 (15.5) 212 (84.5) 1.00
1–3 years 125 (32.1) 24 (19.2) 101 (80.8) 1.29 (0.74, 2.26)
 3 Years 14 (3.6) 1 (7.1) 13 (92.9) 0.42 (0.05, 3.29)
Belief that Cancer can be Cured
Yes 227 (58.4) 24 (10.6) 40 (24.7) 1.00
No 162 (41.6) 40 (24.7) 122(75.3) 2.77 (1.59, 4.82)
Health Satisfaction
Poor/Fair 166 (42.6) 48 (21.4) 176 (78.6) 2.56 (1.39, 4.69)
Good 224 (57.4) 16 (9.6) 150 (90.4) 1.00
Presence of Other chronic Illness
Yes 81 (20.8) 19 (23.5) 62 (76.5) 1.80 (0.98, 3.29)
No 309 (79.2) 45 (14.6) 264 (85.4) 1.00
Pain complaint in NRS
< = 3 121 (31.0) 6 (5.0) 115 (95.0) 1.00
>3 269 (69.0) 58(21.6) 211 (78.4) 5.27 (2.20, 12.58)
Pain complaint in VRS
None/Mild 147 (37.7) 5 (3.4) 142 (96.6) 1.00
Moderate 144 (36.9) 22 (15.3) 122 (84.7) 5.12 (1.88, 13.93)
Severe 99 (25.4) 37 (37.4) 62 (62.6) 16.9 (6.36, 45.18)
https://doi.org/10.1371/journal.pone.0193713.t003
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source of income, being in follow up and poor satisfaction with care) were also associated sig-
nificantly with the score based MDD. (S1 Table).
Magnitude of pain complaint
As seen in Table 4; the prevalence of pain complaint measured with VRS was 62.3% (95% CI;
57.4, 62.3) and 69.0% (95% CI; 64.3, 73.4) measured with NRS (a rating of> 3, which repre-
sents impairing pain). In VRS assessment, 36.9% (95% CI; 32.2, 41.8) rated their pain within
the past two weeks as moderate and 25.4% (95% CI; 21.3, 29.9) rated as severe. Again, mea-
sured with NRS, 26.2% (95% CI; 22.0, 30.7) of the participants rated the pain they encountered
within the last two weeks as 10 which is the most severe pain imaginable. Among the overall
participants, 48.5% (95% CI; 43.5, 53.4) were receiving pain medication, which is almost 3/4th
of participants with the complaints.
Factors associated with depressive symptoms
As briefed in Table 5; in a fully adjusted model, perceived social support and belief about can-
cer curability and occurrence of pain were significantly associated with the likelihood of hav-
ing major depression. Those with a perception of poor social support were more likely to have
a major depression [Adjusted OR (95%CI) = 2.46(1, 21, 5.00)]. Similarly, those who don’t
believe that cancer can be cured were more likely to have a major depression [Adjusted OR
(95%CI) = 2.48(1, 30, 4.70)].
Fig 1. Functional impairment among the DSM related criterion depressed adult cancer patients.
https://doi.org/10.1371/journal.pone.0193713.g001
Fig 2. Functional impairment among the PHQ-9 score cut off depression subtypes on adult cancer patients.
https://doi.org/10.1371/journal.pone.0193713.g002
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Measured with VRS, severe pain [Adjusted OR (95%CI) = 13.17 (4.80, 36.10)] and moder-
ate pain [Adjusted OR (95%CI) = 4.71(1.70, 13.09)] were significantly associated with
increased likelihood of having major depression. Similarly, odds of having a major depression
was more than four times higher among those with pain score of more than three in the NRS.
Fig 3. Proportions of depressive symptoms among the depression subtypes.
https://doi.org/10.1371/journal.pone.0193713.g003
Table 4. Prevalence of depression, pain and related factors among study participants (n = 390).
Clinical characteristics (n = 390) Number (%) Positive 95%CI
Depression
Major depression 64 (16.4) 13.1, 20.4
Subthreshold depression 68 (17.4) 14.0, 21.5
Suicidal ideation 72 (18.5) 9.1, 21.2
Functional Impairment 268(68.7) 64.0, 73.2
Pain complaint in the last 2 weeks
As measured by VRS
No 89 (22.8) 18.9, 27.2
Mild 58(14.9) 11.6, 18.7
Moderate 144(36.9) 32.2, 41.8
Severe 99(25.4) 21.3, 29.9
As measured by NRS
NRS >3 269(69.0) 64.3, 73.4
Under pain medication(n = 390) 189(48.5) 43.5, 53.4
VRS = Verbal Rating Scale
NRS = Numeral Rating Scale
https://doi.org/10.1371/journal.pone.0193713.t004
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Discussion
This study finds a high prevalence of uncontrolled pain, which was also associated with symp-
toms of major depression. Almost 70% of those with depression had pain complaints.
The prevalence of depression in patients with cancer in this tertiary center is higher when
compared to the prevalence of the general population in Ethiopia. The limited studies available
from Ethiopia are population (community) based and report a prevalence ranging from 1.2%
to 12% [22, 39–43]. The only study conducted in one of the tertiary hospitals in Addis Ababa
among people attending the hospital service reported a prevalence of 12.6% [31]. The preva-
lence in our report was higher than that reported in this clinical sample. Studies in Ethiopia
have used different instruments to establish the period prevalence of depression: Self-Report-
ing Questionnaire [42, 43], Composite International Diagnostic Interview[22, 39–41] and the
Patient Health Questionnaire[31]. Comparing the prevalence of co-morbid depression in
patients with cancer in our sample against the broader worldwide report, including those of
low and middle income countries, the prevalence figure reported in our study falls within the
range of the worldwide report albeit at the lower margins. However, functional impairment as
a result of depressive symptoms was higher in our study compared with what was found in
Table 5. Fully adjusted effects of selected socio-demographic and clinical characteristics on the odds of being
depressed.
Patient characteristics Crude
OR (95% CI)
Adjusted
OR (95% CI)
Educational status
No formal education 1.62(0.67, 3.95) 1.30 (0.40, 4.19)
Primary Education (Grade 1–8) 2.45 (1.00, 5.98) 2.58 (0.80, 8.36)
Secondary Education (Grade 9–12) 1.58(0.65, 3.81) 1.47 (0.51, 4.29)
Higher Education (Anything above grade 12 e.g. Diploma, Degree,. . . .) 1.00 1.00
Regular source of income
Yes 1.00 1.00
No 2.07 (1.25, 3.80) 1.59 (0.72, 3.52)
Perceived Social support
Good 1.00 1.00
Poor 2.45 (1.34, 4.50) 2.46 (1.21, 5.00)
Health satisfaction
Poor 2.56 (1.39, 4.69) 1.50 (0.76, 2.95)
Good 1.00 1.00
Belief that cancer can be Cured
Yes 1.00 1.00
No 2.77 (1.59, 4.82) 2.48 (1.30, 4.70)
Pain complaint in NRS
< = 3 1.00
>3 5.27 (2.20, 12.58) 4.49 (1.84, 11.00)
Pain complaint in VRS£
None/Mild 1.00 1.00
Moderate 5.12 (1.88, 13.93) 4.71 (1.70, 13.09)
Severe 16.9 (6.36, 45.18) 13.17 (4.80, 36.10)
 All effects reported in the table are adjusted for each other and also for pain complain in VRS.
£ = The effect of pain complaint in VRS is not adjusted for pain complaint in NRS because of multi-coliniarity but it
is adjusted for all variables indicated in the table.
https://doi.org/10.1371/journal.pone.0193713.t005
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both high and middle income countries. In the later settings, the prevalence of co-morbid
depression ranged from 10% to 58% [15, 16, 18, 25, 28, 44–47]. Rate of depression among can-
cer patients [46, 48] was higher in studies from the Middle East, which appears to be a reflec-
tion of the overall higher prevalence of depression in these countries [21]. Nevertheless,
systematic reviews have been consistent with our finding [44, 49].
Studies from Asia and Africa are few in number; however, they have reported higher preva-
lence. Thus studies from Pakistan and Nigeria reported a prevalence of 61.6% [16] and 37.2%
[25]. Again the higher rate in patients from Pakistan might have been a reflection of the gener-
ally higher rate of depression in the setting [50]. The study from Nigeria was based on inpa-
tients with more severe illness and pain, which may be the reason for the higher prevalence.
Unmanaged pain was high in our study population but these values fall within the reported
prevalence of pain among patients taking anticancer therapy worldwide. A systematic review,
mostly based on studies from high income countries, found a prevalence of 59% [51]; similarly
a study from Netherlands reported a 44% prevalence [24]. Figures from high and upper middle
income countries report lower prevalence, which might be due to a better pain management
and an earlier diagnosis and treatment. On the other hand studies from low income countries
report higher prevalence. For example, a study from Nigeria reported a prevalence of 87.1%
[25]of moderate and severe pain. Although this high figure might relate to the nature of the
sample, the higher rate of depression in the Nigerian sample compared to ours might also be
relevant.
Consistent with previous literature, this study shows the strong association between depres-
sion and cancer pain where the odds of having a major depression is more than four times
higher in those with pain complaints. In using a VRS the odds of having a major depression
shows an increasing trend towards severity of pain. Different studies in different setups have
shown association between depression and pain, prevalence of pain was observed to be much
higher together with a depressive symptom than one condition alone[27, 52–54]. Such strong
associations were described in both low income [25],high and middle income settings[47, 55].
Studies suggest that pain is a common symptom of depression and again the presence of pain
can negatively affect the recognition and treatment of depression making their coexistence a
vicious cycle. In some cases pain can be considered as a sign of severity of a disease so patients
with pain might think that the situation is getting worse and loose hope, increasing the number
of depressed patients, or in other cases depression can sensitizes patients to feel pain and this
might exacerbate the number of depressed patients in those with pain complaint. Functional
impairment as the result of the depressive symptoms was higher in our study compared with
what was found in both high and middle income countries like the report from Indiana (43%)
[55], Iran (19.7%)[47] and even the Nigerian study (44%)[25]. Our study participants were
either in post operational stage or in advanced cancer stage (III, IV or V).
There are several limitations that should be considered. The study is cross-sectional and
direction of association between pain and cancer could not be established. The study was con-
ducted in the capital city in a tertiary hospital. Although this is the only hospital that provides
radiotherapy and comprehensive cancer care, the participants are more likely to have more
severe illness and also to have more favorable socio-economic status. Therefore, the findings
may not be generalizable to the broader population of patients with cancer. Some of the so-
matic symptoms, which are part of the PHQ9 symptom list, may have been due to the cancer
itself or its treatment rather than due to depression. The impact of treatment and pain relief
was not assessed in this study. We have also used a criterion based diagnosis for clinical utility
reasons than the typical score based diagnosis of depression employed in many studies. The
sensitivity analysis confirmed our assumption that the criterion based diagnosis may be a
more conservative estimate of the prevalence of MDD and that both categories may be
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qualitatively similar. This is the first study of its kind in Ethiopia and one of the very few in
Africa. Therefore, the study is an important contribution to our knowledge regarding the
potential role of depression and pain in the management of cancer in these settings.
Conclusion
This study reveals that a substantial number of adult cancer patients were depressed and have
a suicidal ideation, causing a significant functional impairment. This study clearly demon-
strated a significant association between pain complaint and depression among adult cancer
patients. Therefore psychological and physical pain assessment should be incorporated as part
of standard cancer care.
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